Publication | Open Access
Safety, Adherence and Persistence in a Real-World Cohort of German MS Patients Newly Treated With Ocrelizumab: First Insights From the CONFIDENCE Study
16
Citations
31
References
2022
Year
ML39632, EUPAS22951.
| Year | Citations | |
|---|---|---|
Page 1
Page 1